2,861
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Pooled Phase III Safety Analysis of Sufentanil Sublingual Tablets for Short-Term Treatment of Moderate-to-Severe Acute Pain

, , , , , & show all
Pages 259-271 | Received 20 Nov 2018, Accepted 14 Dec 2018, Published online: 07 Jan 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.